Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR+27.5%
5Y CAGR-4.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+27.5%/yr
Quarterly compound
5Y CAGR
-4.6%/yr
Recent acceleration
Percentile
P74
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 19.36% |
| Q3 2025 | 15.44% |
| Q2 2025 | 18.41% |
| Q1 2025 | -40.10% |
| Q4 2024 | 16.02% |
| Q3 2024 | 14.03% |
| Q2 2024 | 10.53% |
| Q1 2024 | -30.36% |
| Q4 2023 | 21.60% |
| Q3 2023 | -3.49% |
| Q2 2023 | 33.86% |
| Q1 2023 | -28.38% |
| Q4 2022 | 9.35% |
| Q3 2022 | 9.37% |
| Q2 2022 | 21.73% |
| Q1 2022 | -14.63% |
| Q4 2021 | 11.09% |
| Q3 2021 | 7.76% |
| Q2 2021 | 36.30% |
| Q1 2021 | -25.52% |
| Q4 2020 | 24.55% |
| Q3 2020 | 88.83% |
| Q2 2020 | -1.25% |
| Q1 2020 | 0.00% |